Scientists find bacterium can halt dengue virus transmission

April 1, 2010

Dengue fever -- caused by a virus transmitted by mosquitoes -- threatens 2.5 billion people each year and there is no vaccine or treatment. New research by Michigan State University entomologists has found that a bacterium can stop dengue viruses from replicating in the mosquitoes.

"In nature, about 28 percent of mosquito species harbor Wolbachia bacteria, but the mosquitoes that are the primary transmitters of dengue, Aedes aegypti, have no Wolbachia in them," said Zhiyong Xi, MSU assistant professor of entomology and study author. "We found that Wolbachia is able to stop the from replicating. If there is no virus in the mosquito, it can't spread to people, so disease transmission can be blocked."

The research is published in the April 1 issue of the journal .

In earlier work, Xi and colleagues introduced the Wolbachia bacterium into Aedes aegypti mosquitoes by injecting with this parasite. They have maintained the bacterium in the mosquitoes in the lab for nearly six years because it is passed from mothers to offspring.

When a Wolbachia-infected male mates with an uninfected female, the bacterium causes a reproductive abnormality that triggers early embryo death. Wolbachia doesn't affect embryo development when a female contains the same Wolbachia as a male, so the bacterium can spread quickly, infecting an entire mosquito population.

The Wolbachia bacterium can't be passed from mosquitoes to humans.

Another report with similar results was recently published by Australian researchers, though the groups used different strains of the Wolbachia bacterium.

"The strain we used has a 100 percent maternal transmission rate and causes the mosquitoes to live slightly longer," Xi explained. "The strain the Australian researchers used causes the mosquitoes to die a bit sooner. There are advantages to both. The longer the mosquitoes live, the more likely they are to pass on the Wolbachia infection to their offspring and infect the entire population in a shorter timeframe. But if the mosquitoes die earlier, they can't bite people and transmit the dengue virus.

"In both instances, the results demonstrate the potential using the Wolbachia bacterium as a control method for dengue virus."

Xi and colleagues, including Guowu Bian, a post-doctoral research associate in Xi's lab who conducted much of the research for this study, are now working to understand how the Wolbachia stops the dengue virus from replicating in .

"Only when we know the mechanisms underlying Wolbachia-mediated viral interference, will we will be able to why it's happening and further improve the efficiency of the viral interference," he said.

While dengue fever is rare in the continental United States, Hawaii was the site of a dengue epidemic in 2001. Overall, about one-third of the world's population is at risk of contracting dengue fever and up to 100 million people are infected each year. While most people recover in about two weeks, the infection can turn into dengue hemorrhagic fever, which causes bleeding from the nose and gums and can be fatal.

Related Stories

Recommended for you

Groundbreaking investigative effort identifies gonorrhea vaccine candidates

September 19, 2017
Researchers at Oregon State University have identified a pair of proteins that show promise as the basis for a gonorrhea vaccine.

Snail fever progression linked to nitric oxide production

September 14, 2017
Bilharzia, caused by a parasitic worm found in freshwater called Schistosoma, infects around 200 million people globally and its advance can lead to death, especially in children in developing countries.

Systems analysis points to links between Toxoplasma infection and common brain diseases

September 13, 2017
More than 2 billion people - nearly one out of every three humans on earth, including about 60 million people in the United States - have a lifelong infection with the brain-dwelling parasite Toxoplasma gondii.

Study clears important hurdle toward developing an HIV vaccine

September 13, 2017
An international team of researchers has demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV: the ability to generate immune cells that stay in circulation ...

As 'flesh-eating' Leishmania come closer, a vaccine against them does, too

September 13, 2017
Parasites that ulcerate the skin, can disfigure the face, and may fatally mutilate its victim's internal organs are creeping closer to the southern edges of the United States.

Promising clinical trial results could give doctors a new tool against drug-resistant strains of malaria parasite

September 13, 2017
Tulane University researchers have developed a new drug that is effective against non-severe cases of malaria, according to results from an FDA-supervised clinical trial published in the latest issue of The Lancet Infectious ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.